Clinical trials for Atypical hemolytic uremic syndrome
10 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 4NCT07308574Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUSAlexion Pharmaceuticals, Inc.
- RECRUITINGN/ANCT07218536The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in EgyptAstraZeneca · PI: AstraZeneca Clinical Study Information Center
- RECRUITINGPhase 3NCT05935215Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Novartis Pharmaceuticals · PI: Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGNCT06099236A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome PatientsAstraZeneca
- ACTIVE NOT RECRUITINGN/ANCT05985122New Analytic Tools for aHUS and C3G DiagnosisMario Negri Institute for Pharmacological Research · PI: Marina Noris, PhD
- RECRUITINGN/ANCT05805202Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized TherapyMario Negri Institute for Pharmacological Research
- ACTIVE NOT RECRUITINGPhase 3NCT04958265A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Hoffmann-La Roche · PI: Clinical Trials
- ACTIVE NOT RECRUITINGPhase 3NCT04861259A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Hoffmann-La Roche · PI: Clinical Trials
- RECRUITINGNCT04745195Complement Prospective Evaluation of Thrombotic Microangiopathy on EndotheliumMaastricht University Medical Center · PI: Pieter van Paassen, MD, PhD
- RECRUITINGNCT01522183Atypical Hemolytic-Uremic Syndrome (aHUS) RegistryAlexion Pharmaceuticals, Inc. · PI: Nuria Saval